Welcome to our dedicated page for Occidental Pet SEC filings (Ticker: OXY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
From reserve replacement data buried in Occidental’s 300-page annual report to sudden carbon-capture updates tucked inside an 8-K, OXY’s regulatory footprint is as deep as the shale plays it operates. Investors chasing production costs, OxyChem chemical margins, or hedging moves often ask, “Where can I read the Occidental Petroleum quarterly earnings report 10-Q filing?” or “How do I monitor Occidental Petroleum insider trading Form 4 transactions?” Navigating that maze alone is time-consuming.
Stock Titan’s AI-powered reader translates complexity into clarity. We generate plain-language highlights for every document—whether it’s the Occidental Petroleum annual report 10-K simplified, the latest Occidental Petroleum 8-K material events explained, or the Occidental Petroleum proxy statement executive compensation schedule. Need reserve life calculations or carbon-capture capex? They surface instantly. Our alerts for “Occidental Petroleum Form 4 insider transactions real-time” arrive seconds after EDGAR acceptance, so you never miss critical executive stock moves.
Use these insights the way professionals do. Track segment EBIT trends across each Occidental Petroleum earnings report filing analysis, review Occidental Petroleum executive stock transactions Form 4 against incentive targets, and compare production guidance year over year. The platform’s unified dashboard answers natural questions like “understanding Occidental Petroleum SEC documents with AI” and “Occidental Petroleum SEC filings explained simply,” ensuring you spend less time searching and more time acting on data that drives decisions.
Occidental Petroleum (OXY) reported lower Q3 2025 results. Net sales were $6.717 billion versus $7.154 billion a year ago, and diluted EPS was $0.65 versus $0.98. Net income was $842 million versus $1.140 billion.
For the first nine months, net sales were $20.016 billion (flat year over year), operating cash flow was $7.898 billion, and capital expenditures were $5.674 billion. The company reduced total borrowings at face value to $20.815 billion from $24.391 billion, aided by $912 million of warrant exercises and asset divestitures of approximately $760 million (Permian working interests), $840 million (DJ Basin royalty/mineral interests) and $580 million (Permian gas gathering).
Occidental announced an agreement to sell OxyChem to Berkshire Hathaway for $9.7 billion in cash, subject to closing conditions, and plans to allocate the majority of after‑tax proceeds to debt reduction. As of October 31, 2025, common shares outstanding were 985,210,434. The effective tax rate was 28% in Q3, and new tax legislation (OBBB) is expected to reduce 2025 cash taxes.
Occidental Petroleum (OXY) furnished an Item 2.02 report announcing its financial condition and results of operations for the quarter ended September 30, 2025. The details are provided in a press release attached as Exhibit 99.1.
The information in this report and Exhibit 99.1 is furnished, not filed, under the Exchange Act and is not incorporated by reference into other filings unless specifically referenced. A Cover Page Interactive Data File is included as Exhibit 104.
Occidental Petroleum Corporation provided a brief management summary of factors it believes will affect results for
Occidental Petroleum (OXY) reported an insider equity award for its Senior Vice President and COO. On
Each RSU represents a contingent right to receive one share upon vesting, which will occur in three equal annual installments beginning on
Warren E. Buffett, Berkshire Hathaway and National Indemnity report a 32.7% economic interest in Occidental Petroleum (OXY). The filing shows each Reporting Person beneficially owns 348,853,373.38 shares of Occidental common stock, calculated to include warrants exercisable into an aggregate of 83,911,942.38 shares. The Berkshire warrants were originally issued in 2019 and adjusted multiple times: the exercise price lowered to $59.624 per share in 2020 and further adjusted to $59.586 per share with an increase to 83,911,942.38 underlying shares as of July 17, 2025. The filing reports no sole voting or dispositive power and lists only shared voting and dispositive power for the reported holdings.
FAQ
What is the current stock price of Occidental Pet (OXY)?
What is the market cap of Occidental Pet (OXY)?
